Harushige Yokota
Papers
1
Total Citations
5
H-Index
1
About
Harushige Yokota is a leading figure in gynecologic oncology, with a focused expertise in the surgical management of early-stage cervical cancer. His primary research area centers on optimizing radical hysterectomy techniques to reduce invasiveness without compromising oncologic outcomes. Yokota’s most significant contribution is his leadership in the Japan Clinical Oncology Group study, JCOG1101, a pivotal confirmatory trial evaluating modified radical hysterectomy for patients with FIGO stage IB1 cervical cancer with tumors ≤2 cm. This work directly addresses the critical need for less invasive surgical alternatives to the standard, highly morbid Piver class III hysterectomy. By demonstrating the safety and efficacy of a modified approach, his research has the potential to reshape clinical guidelines and improve quality of life for patients. While a recent publication (2023), this landmark study has already garnered 5 citations, signaling its immediate impact and the high regard for his methodical, evidence-based approach. Yokota’s work stands at the forefront of de-escalating surgical intensity in gynecologic oncology, balancing cure with reduced patient burden.
Research Focus
Key Achievements
Top Papers
- 1